Publications by authors named "Giuseppe Traversa"

Claim this Profile
H
Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case-Control Study.
Francesca Colavita, Concetta Castilletti, Giulia Matusali, Silvia Accordini, Salvatore De Masi, Giuseppe Traversa

Vaccines (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What if all participants get the same treatment? An ethical perspective on single arm trials.
Chiara Mannelli, Giuseppe Traversa

J Med Ethics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Access to medicines and inadequate calculation of supplementary healthcare].
Giuseppe Traversa

Recenti Prog Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.
Cristina Morciano, Marco Massari, Maria Cutillo, Valeria Belleudi, Gianluca Trifirò, Giuseppe Traversa

Drug Saf· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Somatropin therapy in Italy during 2019-2022: prevalence and incidence rates estimated by data from the national register and regional health sources.].
Arianna Valerio, Daniela Rotondi, Roberto Da Cas, Flavia Pricci, Giuseppe Traversa

Recenti Prog Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription patterns of venetoclax in acute myeloid leukemia.
Andrealuna Ucciero, Giuseppe Traversa, Alessia Pisterna, Valeria Cardinali, Sofia Sciabolacci

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Priorities and tools to evaluate the effectiveness of Italian National Health Service interventions: spotlight on the current debate].
Lucia Bisceglia, Carla Ancona, Luigi Bisanti, Silvia Candela, Elisabetta Listorti, Giuseppe Traversa

Epidemiol Prev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy.
Francesca Menniti-Ippolito, Alfonso Mele, Roberto Da Cas, Salvatore De Masi, Flavia Chiarotti, Giuseppe Traversa

J Nephrol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy.
Francesca Menniti-Ippolito, Alfonso Mele, Roberto Da Cas, Salvatore De Masi, Flavia Chiarotti, Giuseppe Traversa

J Nephrol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Protect the experts' work.].
Giuseppe Traversa

Recenti Prog Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[About the (pseudo)reorganisation of the Italian Medicines Agency].
Giuseppe Traversa

Epidemiol Prev· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The timelines for the price and reimbursement authorization in Italy 2018-2020.
Valentina Gallo, Eva Alessi, Simona Montilla, Gianluca Altamura, Giuseppe Traversa

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of price competition in Italian pharmaceutical off-patent market.
Serena Perna, Agnese Cangini, Roberto Marini, Maria Alessandra Guerrizio, Roberto Da Cas, Giuseppe Traversa

Front Med (Lausanne)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Fluoroquinolone Use in Primary Care on the Development and Gradual Decay of Resistance to Fluoroquinolones: A Matched Case-Control Study.
Peter Konstantin Kurotschka, Chiara Fulgenzio, Roberto Da Cas, Giuseppe Traversa, Gianluigi Ferrante

Antibiotics (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Scientific rigor and attention to values. Memory of Alessandro Liberati.].
Giuseppe Traversa

Recenti Prog Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Turmeric (Curcuma longa L.) food supplements and hepatotoxicity: an integrated evaluation approach.
Francesca Menniti-Ippolito, Ilaria Ippoliti, Augusto Alberto Pastorelli, Ilaria Altieri, Francesco Scalise, Giuseppe Traversa

Ann Ist Super Sanita· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medicines use in Italy. 2020 OsMed National Report.].
Simona Zito, Filomena Fortinguerra, Andrea Pierantozzi, Fabio Ambrosino, Giuseppe Traversa

Recenti Prog Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Prior Antibiotic Use in Primary Care on Resistance to Third Generation Cephalosporins: A Case-Control Study.
Chiara Fulgenzio, Marco Massari, Giuseppe Traversa, Roberto Da Cas, Gianluigi Ferrante

Antibiotics (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of switching between rituximab biosimilars in onco-hematology.
Silvana A M Urru, Stefania Spila Alegiani, Anna Guella, Giuseppe Traversa, Annalisa Campomori

Sci Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy.
Adriana Ammassari, Aurora Di Filippo, Maria Paola Trotta, Giuseppe Traversa, Andrea Pierantozzi

JAMA Netw Open· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Ylenia Ingrasciotta, Janet Sultana, Dario Formica, Valentina Ientile, Andrea Aiello, Giuseppe Traversa

Pharmacoepidemiol Drug Saf· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.
Ylenia Ingrasciotta, Valeria Belleudi, Francesco Trotta, Antonio Addis, Andrea Fontana, Giuseppe Traversa

BioDrugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study.
Valeria Belleudi, Francesco Trotta, Antonio Addis, Ylenia Ingrasciotta, Valentina Ientile, Giuseppe Traversa

Drug Saf· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy.
Francesco Trotta, Flavia Mayer, Francesco Barone-Adesi, Immacolata Esposito, Ranadhir Punreddy, Giuseppe Traversa

BMJ Open· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The cost of drugs to guarantee the challenges of the National Health Service].
Giuseppe Traversa

Assist Inferm Ric· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis